CF
ROIV icon

Corebridge Financial’s Roivant Sciences ROIV Stock Holding History

Corebridge Financial’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-464,990
Closed -$4.69M – 2227
2025
Q1 		$4.69M Sell
464,990
-20,962
-4% -$227K 0.03% 712
2024
Q4 		$5.75M Sell
485,952
-29,931
-6% -$354K 0.03% 659
2024
Q3 		$5.95M Buy
515,883
+87,689
+20% +$998K 0.03% 661
2024
Q2 		$4.53M Buy
+428,194
New +$4.69M 0.02% 740

Other funds holding ROIV

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Corebridge Financial's ROIV Position: Q2 2025 in Review

Corebridge Financial sold out of Roivant Sciences (ROIV) in Q2 2025, closing a stake of 464,990 shares — an estimated $4.69M sold.

Corebridge Financial first reported a position in ROIV in Q2 2024 and held it in 4 quarters. The position peaked at $5.95M in Q3 2024. 337 funds tracked by Wall St. Rank hold ROIV as of Q2 2025.

  • Corebridge Financial reported no remaining Roivant Sciences position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 464,990 Roivant Sciences shares in Q2 2025, an estimated $4.69M.
  • Corebridge Financial first reported a position in Roivant Sciences in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Roivant Sciences position peaked at $5.95M in Q3 2024.
  • 337 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.